Literature DB >> 22157960

Predictive and prognostic factors for non-small cell lung cancer--potholes in the road to the promised land.

Adi F Gazdar, Joan H Schiller.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22157960     DOI: 10.1093/jnci/djr497

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  The evolving role of the pathologist in the management of lung cancer.

Authors:  Adi F Gazdar
Journal:  Lung Cancer Manag       Date:  2012

2.  Precision medicine for cancer patients: lessons learned and the path forward.

Authors:  Adi F Gazdar; John D Minna
Journal:  J Natl Cancer Inst       Date:  2013-08-20       Impact factor: 13.506

3.  Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.

Authors:  David D Stenehjem; Brandon K Bellows; Kraig M Yager; Joshua Jones; Rajesh Kaldate; Uwe Siebert; Diana I Brixner
Journal:  Oncologist       Date:  2015-11-27

4.  Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.

Authors:  Edna Gordian; Eric A Welsh; Nicholas Gimbrone; Erin M Siegel; David Shibata; Ben C Creelan; William Douglas Cress; Steven A Eschrich; Eric B Haura; Teresita Muñoz-Antonia
Journal:  Oncotarget       Date:  2019-01-25

5.  Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer

Authors:  Özgür Önal; Murat Koçer; Hande Nur Eroğlu; Servet Derya Yilmaz; Ismet Eroğlu; Dilek Karadoğan
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.